Lenvima 10 mg

LENVIMA 10 MG capsules contain lenvatinib mesylate, a medication used to treat certain types of cancer. This oral medication is designed to target specific proteins involved in cancer cell growth.

LENVIMA 10 MG capsules are primarily used in the treatment of advanced thyroid cancer and certain types of kidney cancer. Lenvatinib mesylate works by inhibiting the growth of cancer cells, making it a targeted therapy option for these conditions. Patients often wonder, 'What is LENVIMA used for?' and the answer lies in its ability to interfere with the blood supply to tumors, slowing their progression.

Common effects of LENVIMA 10 MG capsules may include fatigue, diarrhea, and high blood pressure. Some users also report appetite loss and hand-foot syndrome, which can cause redness and swelling on the palms and soles. These effects can vary from person to person and may require monitoring by a healthcare professional.

LENVIMA 10 MG capsules should be handled with care, as they are intended for specific medical use. It is important to follow the guidance of a healthcare provider when taking this medication. Pregnant women or those planning to become pregnant should discuss the risks with their doctor, as LENVIMA may not be suitable for everyone.

LENVIMA 10 MG capsules can interact with other medications, including those that affect liver enzymes. Alcohol and certain over-the-counter drugs may also interact with lenvatinib mesylate, so it is advisable to consult a healthcare provider before combining treatments. Always inform your doctor about all medications you are taking to avoid potential interactions.